With a team of nearly 20 professionals from medical and financial backgrounds, Jianxin Capital, a Cci Capital Ltd, focuses on investing in the biomedicine, medical equipment, diagnostic reagents, medical services, and other major health fields. Founded in 2010 and headquartered in Shanghai, China, the company's investment team has rich medical and financial investment, management, and entrepreneurial experience, enabling them to create value for enterprises and investors by making prospective investment layouts according to the development trends of the industry. Additionally, they offer a full range of value-added services, including product development, industrialization, management, and financial investment, to meet the needs of the invested enterprises.